XS3081797964 · Corp · EUR

Teva Pharmaceutical Finance Nether 4.13% 2031/06

MID PRICE
117.22
par = 100
YIELD TO MAT.
4.21%
semi-annual
COUPON
4.130%
semi-annual · fixed
MATURITY
2031-06-01
bullet · 5.08y
OUTSTANDING
not disclosed
AS OF
2026-05-01
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
4.46 y
1bp ↑ ≈ -0.045% P&L
Convexity
23.58
higher = more curvature
Years to maturity
5.08 y
YTM source
Ingested
Fund disclosure
G-spread
+143 bps
vs ECB AAA curve · 2026-04-29
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Global High Yield Corporate Bond
iShares
Global HY Corporate$152K▲ $4950.07%2026-05-01
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-01

Institutional footprint · signal-level holdings

0/ 100
Interpretation. Thin coverage — below signal threshold
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$152K
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
117,220 EUR
137,172 USD
FX SOURCE
ECB · CoinGecko
PRICE
117.22

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
TEVA 4 1/8 06/01/31
FIGI
BBG01V434X57
ISIN
XS3081797964
Type
Corp
Issued
2025-05-28
Face value
100 EUR
Ticker
TEVA 4.125 06/01/31
Sec. type
EURO-ZONE
Seniority
Senior Unsecured

Issuer curve

TEVA · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.